Differential cellular responses to FDA-approved nanomedicines: an exploration of albumin-based nanocarriers and liposomes in protein corona formation

Author:

Putri Athika Darumas12ORCID,Hsu Ming-Jen3,Han Chia-Li4,Chao Fang-Ching5,Hsu Chun-Hua6ORCID,Lorenz Christian D.7ORCID,Hsieh Chien-Ming18ORCID

Affiliation:

1. School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, 11031, Taiwan

2. Semarang College of Pharmaceutical Sciences (STIFAR), Semarang City, 50192, Indonesia

3. Department of Pharmacology, Taipei Medical University, Taipei, 11031, Taiwan

4. Master Program in Clinical Genomics and Proteomics, College of Pharmacy, Taipei Medical University, Taipei, 11031, Taiwan

5. Université Paris-Saclay, CNRS UMR 8612, Institut Galien Paris-Saclay, Châtenay-Malabry, France

6. Department of Agricultural Chemistry, National Taiwan University, Taipei, 10617, Taiwan

7. Biological Physics and Soft Matter Group, Department of Physics, King's College London, London WC2R 2LS, UK

8. Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, 11031, Taiwan

Abstract

Albumin nanoparticles attract less serum protein adsorption than liposomes and hard corona proteins on albumin nanoparticles elicit higher cellular uptake. Coarse-grained molecular simulations reveal the biological mechanism of protein corona.

Funder

Ministry of Science and Technology, Taiwan

National Science and Technology Council

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3